Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps

INTRODUCTION: The serum periostin level is a promising biomarker of type 2- high inflammation pattern of bronchial asthma. It has been proven that serum periostin levels decrease in response to systemic and inhaled corticosteroid (ICS) therapy. However, we have only limited knowledge about changes i...

Descripción completa

Detalles Bibliográficos
Autores principales: Novosad, Jakub, Krčmová, Irena, Bartoš, Vladimír, Drahošová, Marcela, Vaník, Petr, Růžičková-Kirchnerová, Olga, Teřl, Milan, Krejsek, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262810/
https://www.ncbi.nlm.nih.gov/pubmed/32489361
http://dx.doi.org/10.5114/ada.2020.94842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262810/
https://www.ncbi.nlm.nih.gov/pubmed/32489361
http://dx.doi.org/10.5114/ada.2020.94842

Ejemplares similares